Inhibition of HIV Budding by a Genetically Selected Cyclic Peptide Targeting the Gag−TSG101 Interaction

Tavassoli, Ali, Lu, Quan, Gam, Jongsik, Pan, Hui, Benkovic, Stephen J., Cohen, Stanley N.·2008·ACS Chemical Biology
DOI 10.1021/cb800193n

Cited by (156)

Items 101–156 of 156

  1. Natural Cyclic Peptides as Clinical and Future Therapeutics
    Smritilekha Bera, Dhananjoy Mondal · 2019 · Current Organic Chemistry
  2. Genetically Encoded Whole Cell Biosensor for Drug Discovery of HIF-1 Interaction Inhibitors
    Louis H. Scott, Mark J Wigglesworth, Verena Siewers, Andrew M. Davis, Florian David · 2022 · ACS Synthetic Biology
  3. Recent Advances Towards the Development of a Potent Antiviral Against the Hepatitis E Virus
    Saumya Anang, Nidhi Kaushik, Milan Surjit · 2018 · Journal of Clinical and Translational Hepatology
  4. Update on the molecular and cellular biology of hepatitis E virus and therapeutic opportunities
    Laura Corneillie, Léa Mézière, Claire Montpellier, Benjamin Drouet, Cécile‐Marie Aliouat‐Denis, Laurence Cocquerel · 2026 · Antiviral Research
  5. Cyclic Peptides as Protein Kinase Modulators and Their Involvement in the Treatment of Diverse Human Diseases
    Lorena Martínez Alcantar, Laura Hernández-Padilla, Alma Laura Díaz-Pérez, Lizbeth Guadalupe Villalón-Magallán, Mayra Xóchitl Durán-Maldonado, César Díaz‐Pérez, Marlene Estefania Campos-Morales, Citlali Figueroa-Guzmán, Jesús Campos‐García · 2024 · Kinases and Phosphatases
  6. Head‐to‐tail cyclization of side chain‐protected linear peptides to recapitulate genetically‐encoded cyclized peptides
    Samir Bouayad‐Gervais, Daniel J. St‐Cyr, Mathieu Courcelles, Éric Bonneil, Florence H. Gohard, Pierre Thibault, William C. Earnshaw, Mike Tyers · 2022 · Peptide Science
  7. Gag Protein Oriented Supramolecular Nets as Potential HIV Traps
    Xirui Zhou, Ye Liu, Zhentao Huang, Qingxin Yao, Fangfei He, Yuan Gao · 2021 · Bioconjugate Chemistry
  8. Phage display identification of high-affinity ligands for human TSG101-UEV: A structural and thermodynamic study of PTAP recognition
    Javier Murciano‐Calles, Alejandro Rodríguez Martínez, Andrés Palencia, Montserrat Andújar‐Sánchez, Manuel Iglesias-Bexiga, Carles Corbi‐Verge, Pedro Buzón, Javier Ruiz‐Sanz, José C. Martínez, Horacio Pérez‐Sánchez et al. · 2024 · International Journal of Biological Macromolecules
  9. Working title: Molecular involvement of p53‐MDM2 interactome in gastrointestinal cancers
    Yedla Poornachandra, Pranav Bhamidipati, Riyaz Syed, Ramars Amanchy · 2024 · Cell Biochemistry and Function
  10. A heterocyclic compound inhibits viral release by inducing cell surface BST2/Tetherin/CD317/HM1.24
    Perpetual Nyame, Akihiro Togami, Tomofumi Yoshida, Takuya Masunaga, MST Monira Begum, Hiromi Terasawa, Nami Monde, Yurika Tahara, Reiko J. Tanaka, Yuetsu Tanaka et al. · 2024 · Journal of Biological Chemistry
  11. Understanding binding affinity and specificity of modular protein domains: A focus in ligand design for the polyproline-binding families
    José C. Martínez, Francisco Castillo, Javier Ruiz‐Sanz, Javier Murciano‐Calles, A. Cámara-Artigas, Irene Luque · 2022 · Advances in protein chemistry and structural biology
  12. A Versatile Strategy for Screening Custom‐Designed Warhead‐Armed Cyclic Peptide Inhibitors
    Deokhee Kang, Do-Wook Kim, Joo‐Chan Kim, Hee‐Sung Park · 2022 · Angewandte Chemie International Edition
  13. Protein–Protein Interaction Inhibitors in Cancer
    Ian Robert Hardcastle · 2016 · Elsevier eBooks
  14. The Discovery of Peptide Macrocycle Rescuers of Pathogenic Protein Misfolding and Aggregation by Integrating SICLOPPS Technology and Ultrahigh-Throughput Screening in Bacteria
    Dafni Chrysanthi Delivoria, Γεώργιος Σκρέτας · 2021 · Methods in molecular biology
  15. Literature Search and Review
    Doug Auld, Anton M. Simeonov, Wendy Lea, Craig J. Thomas · 2010 · Assay and Drug Development Technologies
  16. Analysis and Prediction of Chymotrypsin Substrate Preferences through Large Data Acquisition with Target‐Free mRNA Display
    Sabrina E. Iskandar, Lindsey Guan, Rumit Maini, Christopher J. Hipolito, Congliang Sun, Lisa A. Vasicek, Dan Sindhikara, Adam B. Weinglass, Sanjay Adrian Saldanha · 2024 · ChemBioChem
  17. Interactions of HIV-1 Proteins as Targets for Developing Anti-HIV-1 Peptides
    Koushik Chandra, Michal Maes, Assaf Friedler · 2015 · Future Medicinal Chemistry
  18. Synthesis of Macrocyclic Organo-peptide Hybrids from Ribosomal Polypeptide Precursors via CuAAC-/Hydrazide-Mediated Cyclization
    Jessica M. Smith, Rudi Fasan · 2014 · Methods in molecular biology
  19. Genetic Selections with SICLOPPS Libraries: Toward the Identification of Novel Protein–Protein Interaction Inhibitors and Chemical Tools
    Francisco Castillo, Ali Tavassoli · 2019 · Methods in molecular biology
  20. Molecular Events in Late Stages of HIV-1 Replication.
    Jessica A. Sutton, Dominique R. Dotson, Xinhong Dong · 2013 · PubMed
  21. Exploring the druggability of the UEV domain of human TSG101 in search for broad‐spectrum antivirals
    Fernando Montero, Marisa Parra‐López, Alejandro Rodríguez Martínez, Javier Murciano‐Calles, Pedro Buzón, Ziying Han, Lian‐Yu Lin, María C. Ramos, Javier Ruiz‐Sanz, José C. Martínez et al. · 2024 · Protein Science
  22. Fluorescence lifetime imaging applied to multiwell plate FRET assays for high content analysis
    Dominic Alibhai · 2013
  23. Tumor Suppressor Gene 101
    Carol A. Carter · 2018 · Elsevier eBooks
  24. Short Amphiphiles or Micelle Peptides May Help to Fight Against COVID-19
    Sounik Manna, Trinath Chowdhury, Santi M. Mandal, Sujata Maiti Choudhury · 2022 · Current Protein and Peptide Science
  25. Drug Design Methods to Regulate Protein–Protein Interactions
    Krishna Mohan Poluri, Khushboo Gulati, Deepak Kumar Tripathi, Nupur Nagar · 2023 · Springer eBooks
  26. The ESCRT pathway and HIV-1 budding: A paradigm of viral exploitation of cellular regulation
    Mahmoud Mohammad Yaseen, Nizar Mohammad Abuharfeil · 2026 · Biochimica et Biophysica Acta (BBA) - Biomembranes
  27. Macrocyclic peptides and peptidomimetics as modulators of protein–protein interactions
    Rajesh Parmar, Vidit Shrivastava, Gurmeet Kaur, Bhupesh Goyal, Rahul Jain · 2026 · RSC Medicinal Chemistry
  28. A Versatile Strategy for Screening Custom‐Designed Warhead‐Armed Cyclic Peptide Inhibitors
    Deokhee Kang, Do-Wook Kim, Joo‐Chan Kim, Hee‐Sung Park · 2022 · Angewandte Chemie
  29. Virus Assembly as a Target for Antiretroviral Therapy
    Eric Barklis · 2013 · Springer eBooks
  30. Literature Search and Review
    Doug Auld, Anton M. Simeonov, Craig J. Thomas · 2009 · Assay and Drug Development Technologies
  31. Macrocyclic Organo‐Peptide Hybrids by Intein‐Mediated Ligation: Synthesis and Applications
    John R. Frost, Rudi Fasan · 2017 · Wiley eBooks
  32. Biological and Hybrid Biological/Chemical Strategies in Diversity Generation of Peptidic Macrocycles
    Francesca Vitali, Rudi Fasan · 2017
  33. A novel approach for selecting potent peptide inhibitors of the SARS-CoV2-Mpro protease
    Alexander V. Pisarchik · 2021 · Research Square
  34. Targeting Disease with Small Molecule Inhibitors of Protein–Protein Interactions
    Fedor Forafonov, Elena Miranda, Ida Karin Nordgren, Ali Tavassoli · 2010
  35. Development of a high throughput cell-based assay to screen for inhibitors of HIV-1 Vpr oligomerization
    Courtney Zych · 2011 · D-Scholarship@Pitt (University of Pittsburgh)
  36. Compounds Derived from Birch Trees that Inhibit HIV-1 Replication
    Casey R. Dorr · 2011 · University of Minnesota Digital Conservancy (University of Minnesota)
  37. A3G complexes: A novel role of A3G in restricting the late steps of HIV-1 replication
    Kenneth L. Martin · 2011
  38. Synthetic Biology Will Reinvigorate New Generation Drugs, Vaccines and Biofuels Research and Development
    Sami Ullah Jan, Burhan Ullah, Aimal Khan, Muhammad Asif Shahzad, Atif Shafique, Muhammad Ali Abbas · 2014
  39. Cell-based assays for identifying, validating and optimizing protein–protein interaction modulators
    Abigail L. Male, Ali Tavassoli · 2013
  40. Development of a fluorescent three‐hybrid system for the identification of protein‐protein associators
    Andrew D. Foster, Chun‐wa Chung, Michael M. Hann, Graham L. Simpson, Ali Tavassoli · 2020 · Peptide Science
  41. Future directions
    Alexander L. Breeze · 2013
  42. Faculty Opinions recommendation of Antiviral activities and applications of ribosomally synthesized and post-translationally modified peptides (RiPPs).
    Jens‐Michael Schröder · 2021 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  43. Engineering constrained peptides to target nucleic acids: G-quadruplex recognition and imaging
    Yaneva Militsa Yavorova · 2021
  44. Backbone NMR resonance assignment of the apo human Tsg101-UEV domain
    Danai Moschidi, François‐Xavier Cantrelle, Emmanuelle Boll, Xavier Hanoulle · 2023 · Biomolecular NMR Assignments
  45. Development of recombinant lantibiotics and their potent uses
    Venkata Giridhar Poosarla, Nagaveni Shivshetty, Sanjay Nagarajan, Gobinath Rajagopalan · 2023 · Elsevier eBooks
  46. Cell line-dependent release of quasi-enveloped hepatitis E virus reveals alternative Golgi-associated egress in the absence of pORF3
    Nele Gremmel, Mirco Glitscher, Johannes Scholz, Ashish Kumar Gadicherla, Reimar Johne, Eberhard Hildt, Paul Becher · 2025 · Frontiers in Cellular and Infection Microbiology
  47. Protein-protein interaction inhibitors in cancer
    Ian Robert Hardcastle, Jennyfer Goujon-Ricci, William Isaac Thompson · 2026 · Elsevier eBooks
  48. Caractérisation du virus BK et rôle des vésicules extracellulaires sur sa pathogénicité
    Lynda Handala · 2020
  49. RaPID Selection of Backbone Macrocyclic Peptides Targeting Akt2
    Koki Shinbara, Ekishin Yanagi, Ayaka Aizawa, Takayuki Katoh, Hiroaki Suga · 2026 · Angewandte Chemie International Edition
  50. Structural and functional study of the HEV ORF3 protein by solution NMR
    Danai Moschidi · 2023
  51. RaPID Selection of Backbone Macrocyclic Peptides Targeting Akt2
    Koki Shinbara, Ekishin Yanagi, Ayaka Aizawa, Takayuki Katoh, Hiroaki Suga · 2026 · Angewandte Chemie
  52. Discovery of a novel class of broad-spectrum antivirals targeting the UEV domain of TSG101 in the host ESCRT pathway
    Daniele Rubini, Marisa Parra‐López, Julia Holzerland, Alejandro Rodríguez-Martínez, Maria Grazia Martina, Martina Eleonora Valenti, Maria C. Ramos, Francisco Castillo, Ronald N. Harty, Kristina Lanko et al. · 2026 · European Journal of Medicinal Chemistry
  53. De Novo Discovery of Bioactive Cyclic Peptides via Cellular Selection of Genetically Encoded Libraries
    Linwei Yang, Abhijit Behera, Hannah J. Meyers, Tina Wang · 2026 · ChemBioChem
  54. BindingDB Entry 50010746: Inhibiting Matrix Metalloproteinase-2 Activation by Perturbing Protein-Protein Interactions Using a Cyclic Peptide.
    BindingDB · 2021 · UC San Diego
  55. BindingDB Entry 5640: Targeting Tumour Proliferation with a Small-Molecule Inhibitor of AICAR Transformylase Homodimerization.
    BindingDB · 2012 · UC San Diego
  56. BindingDB Entry 50031378: Application of ring-closing metathesis macrocyclization to the development of Tsg101-binding antagonists.
    BindingDB · 2010 · UC San Diego